Regulation of P2X7 receptor expression and function in the brain

被引:53
作者
Jimenez-Mateos, Eva M. [1 ,2 ]
Smith, Jonathon [1 ,3 ]
Nicke, Annette [4 ]
Engel, Tobias [1 ,3 ]
机构
[1] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin, Ireland
[2] Univ Dublin, Trinity Coll Dublin, Sch Med, Discipline Physiol, Dublin, Ireland
[3] FutureNeuro Res Ctr, Dublin, Ireland
[4] Ludwig Maximilian Univ Munchen, Walther Straub Inst Pharmacol & Toxicol, D-80336 Munich, Germany
基金
欧盟地平线“2020”;
关键词
ATP; Purinergic P2X7 receptor; Expression; Brain; P2X(7) RECEPTOR; HUNTINGTONS-DISEASE; ALZHEIMERS-DISEASE; STATUS EPILEPTICUS; ADP-RIBOSYLATION; SPLICE VARIANTS; ATP; CHANNEL; MICROGLIA; GENES;
D O I
10.1016/j.brainresbull.2018.12.008
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Because of its prominent role in driving inflammatory processes, the ATP-gated purinergic P2X7 receptor has attracted much attention over the past decade as a potential therapeutic target for numerous human conditions, particularly diseases of the central nervous system, including neurodegenerative diseases (e.g. Alzheimer's and Huntington's disease), psychiatric disorders (e.g. schizophrenia and depression) and the neurological disease, epilepsy. Evidence stems from studies using experimental models and patient tissue showing changes in P2X7 expression and function under pathological conditions and beneficial effects provided by P2X7 antagonism. Apart from promoting neuroinflammation, P2X7, however, also impacts on other pathological processes in the brain, including cell death, hyperexcitability, changes in neurotransmitter release and neurogenesis. Reports also suggest a role for P2X7 in the maintenance of blood-brain-barrier integrity. It therefore comes as no surprise that the regulation of P2X7 expression and function is complex, providing tight control on P2X7 activation. Much progress has been made in understanding how P2X7 is regulated during physiological and pathological conditions and what the consequences are of pathological P2X7 expression and function. Regulatory mechanisms altering P2X7 expression include transcriptional and post-translational regulation including nucleotide polymorphisms, promoter regulation via DNA methylation, transcription factors (e.g. Sp1 and HIF-1 alpha), the generation of different splice variants and receptor phosphorylation, glycosylation and palmitoylation. Finally, more recently, reports have also shown P2X7-targeting by microRNAs, blocking P2X7 translation into functional proteins. The present review provides a broad overview of what is known to-date about the complex regulation of P2X7 expression with a particular emphasis on the brain and how each of these regulatory mechanisms impacts on receptor function and pathology.
引用
收藏
页码:153 / 163
页数:11
相关论文
共 100 条
[1]   PURINOCEPTORS - ARE THERE FAMILIES OF P2X AND P2Y PURINOCEPTORS [J].
ABBRACCHIO, MP ;
BURNSTOCK, G .
PHARMACOLOGY & THERAPEUTICS, 1994, 64 (03) :445-475
[2]   The P2X7 receptor: A main player in inflammation [J].
Adinolfi, Elena ;
Giuliani, Anna Lisa ;
De Marchi, Elena ;
Pegoraro, Anna ;
Orioli, Elisa ;
Di Virgilio, Francesco .
BIOCHEMICAL PHARMACOLOGY, 2018, 151 :234-244
[3]   Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor [J].
Adinolfi, Elena ;
Cirillo, Maria ;
Woltersdorf, Ronja ;
Falzoni, Simonetta ;
Chiozzi, Paola ;
Pellegatti, Patrizia ;
Callegari, Maria Giulia ;
Sandona, Doriana ;
Markwardt, Fritz ;
Schmalzing, Guenther ;
Di Virgilio, Francesco .
FASEB JOURNAL, 2010, 24 (09) :3393-3404
[4]   ADP-ribosylation at R125 gates the P2X7 ion channel by presenting a covalent ligand to its nucleotide binding site [J].
Adriouch, Sahil ;
Bannas, Peter ;
Schwarz, Nicole ;
Fliegert, Ralf ;
Guse, Andreas H. ;
Seman, Michel ;
Haag, Friedrich ;
Koch-Nolte, Friedrich .
FASEB JOURNAL, 2008, 22 (03) :861-869
[5]   Silencing of P2X7R by RNA interference in the hippocampus can attenuate morphological and behavioral impact of pilocarpine-induced epilepsy [J].
Amorim, Rebeca Padrao ;
Leao Araujo, Michelle Gasparetti ;
Valero, Jorge ;
Lopes-Cendes, Iscia ;
Bitencourt Pascoal, Vinicius Davila ;
Malva, Joao Oliveira ;
da Silva Fernandes, Maria Jose .
PURINERGIC SIGNALLING, 2017, 13 (04) :467-478
[6]   Emerging challenges of assigning P2X7 receptor function and immunoreactivity in neurons [J].
Anderson, CM ;
Nedergaard, M .
TRENDS IN NEUROSCIENCES, 2006, 29 (05) :257-262
[7]   Co-Expression of Wild-Type P2X7R with Gln460Arg Variant Alters Receptor Function [J].
Aprile-Garcia, Fernando ;
Metzger, Michael W. ;
Paez-Pereda, Marcelo ;
Stadler, Herbert ;
Acuna, Matias ;
Liberman, Ana C. ;
Senin, Sergio A. ;
Gerez, Juan ;
Hoijman, Esteban ;
Refojo, Damian ;
Mitkovski, Miso ;
Panhuysen, Markus ;
Stuehmer, Walter ;
Holsboer, Florian ;
Deussing, Jan M. ;
Arzt, Eduardo .
PLOS ONE, 2016, 11 (03)
[8]   Alternative splicing as a regulator of development and tissue identity [J].
Baralle, Francisco E. ;
Giudice, Jimena .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2017, 18 (07) :437-451
[9]   The ATP-Gated P2X7 Recept or As a Target for the Treatment of Drug-Resistant Epilepsy [J].
Beamer, Edward ;
Fischer, Wolfgang ;
Engel, Tobias .
FRONTIERS IN NEUROSCIENCE, 2017, 11
[10]   P2X receptor channels in chronic pain pathways [J].
Bernier, Louis-Philippe ;
Ase, Ariel R. ;
Seguela, Philippe .
BRITISH JOURNAL OF PHARMACOLOGY, 2018, 175 (12) :2219-2230